SCHEMBL4958962

SCHEMBL4958962

CCCCc1nc2ccccc2c(=O)n1CCN

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.70
PDE4B Q07343 3/20 0.70
PDE4C Q08493 3/20 0.70
PDE4D Q08499 3/20 0.70
SMN1; SMN2 Q16637 2/20 0.62
ATM Q13315 1/20 0.62
LMNA P02545 3/20 0.61
TSHR P16473 2/20 0.61
PTK2B Q14289 1/20 0.58
ALDH1A1 P00352 3/20 0.57
MAPK1 P28482 1/20 0.57
TLR7 Q9NYK1 3/20 0.55
TLR8 Q9NR97 1/20 0.55
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
ADORA3 P0DMS8 1/20 0.49
ADORA1 P30542 1/20 0.49
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4956228 0.99 PDE4A (0.69) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4958108 0.94 PDE4A (0.69) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
Hydrochloric Acid SCHEMBL4955764 0.92 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL1042983 0.89 LMNA (0.64) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL8481498 0.89 LMNA (0.64) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
Hydrochloric Acid SCHEMBL8486883 0.88 LMNA (0.66) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
Hydrochloric Acid SCHEMBL1038937 0.88 LMNA (0.66) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL11501103 0.86 PDE4A (0.70) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4959018 0.82 PDE4A (0.63) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4957608 0.82 PDE4A (0.63) PDE4APDE4BPDE4CPDE4DSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO claimed
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed